Something is shifting inside McDonald’s and it has everything to do with what is happening outside its restaurants. As the use of GLP-1 weight-loss medications like Ozempic and Wegovy continues rising across the United States, the fast food giant is actively testing new menu items designed to meet the changing appetites of its customers. It is a calculated move signaling just how seriously the industry is taking this cultural shift around food and health.
During a recent earnings call, McDonald’s CEO Chris Kempczinski acknowledged that customers using GLP-1 medications eat differently than average diners. They tend to reach for meals that are higher in protein and lower in calories, and they are also cutting back on snacking and sugary beverages. These are not minor behavioral tweaks. They represent a meaningful change in how a growing segment of McDonald’s customer base approaches every meal.
The menu is already adapting but evolution continues
McDonald’s is not starting from scratch. The chain already offers several high-protein options including Snack Wraps, Sausage Biscuit sandwiches and McCrispy Strips—items that naturally align with what GLP-1 users tend to gravitate toward. But leadership has made clear that what exists today is only the beginning of a much larger transformation.
Vice President Jill McDonald confirmed the company has long-term goals to better serve this customer group, though specific details about upcoming additions have not yet been revealed. What is clear is that the chain sees this not as a passing trend but as a sustained shift in how Americans eat. That shift demands a thoughtful, lasting response from the menu upward rather than superficial additions.
McDonald’s is far from alone in this pivot
The move places McDonald’s alongside a growing list of major chains already adapting to the GLP-1 era. Smoothie King was among the first to act, launching a dedicated GLP-1 menu back in 2024 featuring smoothies with extra protein, added fiber and zero grams of added sugar. That direct response to what these medications do to the body’s cravings and digestion set a template others quickly followed.
Olive Garden introduced a lighter portion section to its menu late last year, offering smaller and more affordable entree sizes for diners who simply do not need or want a full plate. Chipotle went the protein-forward route, adding a grilled chicken protein cup that delivers 32 grams of protein in a single serving. Subway rolled out Protein Pockets—compact snack wraps loaded with more than 20 grams of protein—while Shake Shack introduced its Good Fit Menu, which swaps traditional buns for lettuce wraps on several signature items.
The numbers explain why chains are moving fast
The scale of this shift explains why so many chains are responding so quickly. A November poll from the Kaiser Family Foundation found that 12 percent of Americans reported currently taking a GLP-1 drug—a figure that had doubled compared to just six months prior. Originally developed to treat type 2 diabetes, GLP-1 medications have since become widely used as weight-loss tools because they suppress appetite and slow digestion in ways that make overeating far less likely.
That kind of rapid adoption across the general population has real consequences for businesses built around selling large portions of calorie-dense food. For chains like McDonald’s, ignoring the trend was never really an option. The question was always how quickly they could respond and how meaningfully.
Fast food’s fundamental shift is underway
The broader picture is one of an industry in genuine transition. Fast food has long been associated with indulgence, convenience and affordability—and those values are not disappearing. But the definition of convenience is quietly expanding to include food that works with a customer’s health goals rather than against them.
For McDonald’s, a chain that serves tens of millions of people every single day, even a modest menu evolution can reach an enormous audience. The new protein-focused items in testing represent a significant recognition that customer priorities have shifted. Whether these items ultimately make it to the permanent menu remains to be seen, but the direction the company is heading appears unmistakable.
